Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 15 (4), 553-62

Epidemiology of Primary Sclerosing Cholangitis

Affiliations
Review

Epidemiology of Primary Sclerosing Cholangitis

E Schrumpf et al. Best Pract Res Clin Gastroenterol.

Abstract

Many patients suffering from primary sclerosing cholangitis (PSC) have no symptoms--or rather unspecific symptoms. Most patients have a cholestatic biochemical profile, but a specific blood test for the diagnosis of PSC is lacking. The diagnostic test (endoscopic retrograde cholangiography (ERC)) is an invasive procedure with potential complications. Also, in some patients the diagnosis of PSC is not easy, even when ERC has been performed. Therefore true incidence and prevalence data on PSC are extremely few. Nevertheless, it seems well established that the epidemiology of PSC is not the same all over the world. PSC is most often seen in Northern Europe. In this part of the world PSC is also associated with inflammatory bowel disease in most cases--and in the Nordic Countries PSC has become the primary indication for hepatic transplantation.

Similar articles

See all similar articles

Cited by 14 PubMed Central articles

See all "Cited by" articles

LinkOut - more resources

Feedback